Award recordCONTRACT

SOFIE CO.

PIID 36C24820P0034· VHA· 248-NETWORK CONTRACT OFFICE 8 (36C248)· 6505 · DRUGS AND BIOLOGICALS· FY2020· $437,500 net obligations· UEI JV1AHJHGUGG3· VA

Description

PAY FINAL INVOICE (4 DOSES) - OPTION 4 (FY24).

Base award description: AMYLOID FLORBETABEN INJECTIONS

First action · last action
2019-10-21 · 2026-02-09
Transactions
13
First transaction's obligation
$110,000
Base + all options value (sum of deltas)
$437,500
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 13 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$497,500$0Base award · 2019-10-21 · this action $110,000 · running total $110,000Modification P00001 · 2020-07-14 · this action $0 · running total $110,000Modification P00002 · 2020-10-07 · this action $110,000 · running total $220,000Modification P00003 · 2021-03-16 · this action -$47,500 · running total $172,500Modification P00004 · 2021-10-01 · this action $110,000 · running total $282,500Modification P00005 · 2021-12-21 · this action -$37,500 · running total $245,000Modification P00006 · 2022-06-24 · this action $50,000 · running total $295,000Modification P00008 · 2022-10-01 · this action $110,000 · running total $405,000Modification P00009 · 2023-01-11 · this action -$17,500 · running total $387,500Modification P00010 · 2023-10-01 · this action $110,000 · running total $497,500Modification P00011 · 2024-05-14 · this action -$42,500 · running total $455,000Modification P00012 · 2024-11-27 · this action -$27,500 · running total $427,500Modification P00013 · 2026-02-09 · this action $10,000 · running total $437,500
  • Base2019-10-21+$110,000= $110,000
  • Mod P000012020-07-14+$0= $110,000
  • Mod P000022020-10-07+$110,000= $220,000
  • Mod P000032021-03-16-$47,500= $172,500
  • Mod P000042021-10-01+$110,000= $282,500
  • Mod P000052021-12-21-$37,500= $245,000
  • Mod P000062022-06-24+$50,000= $295,000
  • Mod P000082022-10-01+$110,000= $405,000
  • Mod P000092023-01-11-$17,500= $387,500
  • Mod P000102023-10-01+$110,000= $497,500
  • Mod P000112024-05-14-$42,500= $455,000
  • Mod P000122024-11-27-$27,500= $427,500
  • Mod P000132026-02-09+$10,000= $437,500
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2019-10-21+$110,000$110,000AMYLOID FLORBETABEN INJECTIONS
Mod P00001· OTHER ADMINISTRATIVE ACTION2020-07-14+$0$110,000AMYLOID FLORBETABEN INJECTIONS
Mod P00002· EXERCISE AN OPTION2020-10-07+$110,000$220,000AMYLOID FLORBETABEN INJECTIONS OPTION 1
Mod P00003· FUNDING ONLY ACTION2021-03-16−$47,500$172,500REMOVED UNUSED FUNDING AND ITEMS
Mod P00004· EXERCISE AN OPTION2021-10-01+$110,000$282,500EXERCISE OPTION YEAR 2
Mod P00005· FUNDING ONLY ACTION2021-12-21−$37,500$245,000OPTION YEAR 1 DE-OBLIGATION
Mod P00006· FUNDING ONLY ACTION2022-06-24+$50,000$295,000FUNDING INCREASE PO# 546C20054
Mod P00008· EXERCISE AN OPTION2022-10-01+$110,000$405,000OPTION YEAR 3
Mod P00009· FUNDING ONLY ACTION2023-01-11−$17,500$387,500OPTION YEAR 2 DECREASE
Mod P00010· EXERCISE AN OPTION2023-10-01+$110,000$497,500EXERCISE OPTION 4.
Mod P00011· FUNDING ONLY ACTION2024-05-14−$42,500$455,000DECREASE OPTION 3.
Mod P00012· FUNDING ONLY ACTION2024-11-27−$27,500$427,500DECREASE OPTION 4 (FY24).
Mod P00013· FUNDING ONLY ACTION2026-02-09+$10,000$437,500PAY FINAL INVOICE (4 DOSES) - OPTION 4 (FY24).

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI JV1AHJHGUGG3)

AwardOffice · PSC / listingNet obligationsFY
36C25526N0392255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS$357,066FY2026
36C25526N0245255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS$1,172,834FY2026
36C24226N0463242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$624,017FY2026
36C24226N0388242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$830,796FY2026
36C24226D0040242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C25026P0310250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$347,000FY2026

Other recipients under 6505 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24826F0207CSL BEHRING L.L.C.248-NETWORK CONTRACT OFFICE 8 (36C248)$183,903FY2026
36C24826P1108ASD SPECIALTY HEALTHCARE, LLC248-NETWORK CONTRACT OFFICE 8 (36C248)$54,600FY2026
36C24826P1090SIRTEX MEDICAL INC248-NETWORK CONTRACT OFFICE 8 (36C248)$45,825FY2026
36C24826N0511BIOMERIEUX INC248-NETWORK CONTRACT OFFICE 8 (36C248)$61,788FY2026
36C24826N0693MEDI-PHYSICS, INC.248-NETWORK CONTRACT OFFICE 8 (36C248)$111,150FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24820P0034_3600_-NONE-_-NONE- · retrieved 2026-09-26.